“…There is an burning need to design and synthesis of novel prospective dual-active compounds, especially anticancer-antiviral [ [32] , [33] , [34] ]. Our interest is the design, synthesis, and pharmacological evaluation of the heterocyclic compounds, especially those derived from the Biginelli reaction [ [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] ].…”